Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia
Heidi Taipale, Antti O. Tanskanen, Jari Tiihonen
American Journal of Psychiatry (2023) Vol. 180, Iss. 5, pp. 377-385
Closed Access | Times Cited: 19
Cariprazine augmentation of clozapine in schizophrenia—a retrospective chart review
Marcin Siwek, Adrian Andrzej Chrobak, Aleksandra Gorostowicz, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 5
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data
M.W.H. Lochmann van Bennekom, Joanna IntHout, Harm J. Gijsman, et al.
Schizophrenia Research (2024) Vol. 272, pp. 1-11
Closed Access | Times Cited: 3
Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit
Michelle Iris Jakobsen, Julie Perrine Schaug, Jimmi Nielsen, et al.
Nordic Journal of Psychiatry (2023) Vol. 77, Iss. 5, pp. 481-490
Open Access | Times Cited: 8
The management of patients with predominant negative symptoms in Slovakia: A 1-year longitudinal, prospective & multicentric cohort study
Jozef Dragašek, Z.B. Dombi, K. Acsai, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 2
Focus on neurodevelopmental conditions and antipsychotics prescription patterns
Alessandro Serretti
International Clinical Psychopharmacology (2024) Vol. 39, Iss. 4, pp. 215-219
Closed Access | Times Cited: 2
Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder
Mats Bogren, Monica Soltesz, Stephan Hjorth
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 10
Case report: Successful administration of cariprazine in a young, severely ill patient with recurrent relapses of schizophrenia and persistent negative symptoms
Jeļena Vrubļevska
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report
Anzejs Dmuhovskis, Māris Taube
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial
Ravi Anand, Alessio Turolla, Giovanni Chinellato, et al.
Neuropharmacology (2024), pp. 110275-110275
Open Access | Times Cited: 1
Dopamine partial agonists: a discrete class of antipsychotics
David Taylor, R. N. Chithiramohan, Jasdev Grewal, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 3, pp. 272-284
Closed Access | Times Cited: 6
Pharmacotherapy and Emerging Treatment Strategies for Schizophrenia
Jitendra Kumar Sinha, Punya Sachdeva, Faizan Ahmad, et al.
(2023), pp. 149-179
Closed Access | Times Cited: 3
Navigating Schizophrenia Treatment: Balancing Symptom Relief and Long-Term Needs
Ágota Barabássy, Z.B. Dombi, Réka Csehi, et al.
IntechOpen eBooks (2024)
Open Access
Cariprazine in Hospital Treatment of Acute Psychotic Conditions Due to Comorbid Schizophrenia and Chemical Addictions
Г.Ю. Селиванов, Н. А. Бохан, A. P. Otmakhov, et al.
Psikhiatriya (2024) Vol. 22, Iss. 4, pp. 115-128
Open Access
Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report
Johan Sahlsten Schölin, José Rodriguez Cruz, Stephan Hjorth
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
A Survey Study on Clinicians’ Rationale and Attitude Towards the Prescription of Antipsychotic Polypharmacy in the East Perth Metropolitan Area in Western Australia
Suzie Uloma Ajayi, Praveena Arora
Cureus (2023)
Open Access | Times Cited: 1
Cariprazine in offender patient with acute psychosis and aggressive behavior: Case report
Lena Machetanz, Steffen Lau, Johannes Kirchebner
Psychiatry Research Case Reports (2022) Vol. 2, Iss. 1, pp. 100094-100094
Open Access | Times Cited: 1
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume II
Peter Falkai, Z.B. Dombi
Frontiers in Psychiatry (2023) Vol. 14
Open Access
Page 1

Scroll to top